as evidence of NSC motility away from the graft and into the infarct border in severely lesioned animals co-grafted with OECs. These findings support a possible role of OECs as part of an in situ tissue engineering paradigm for transplant mediated repair of ischemic brain lesions.
Introduction
Ischemic stroke is one of the leading causes of disabilityadjusted life-years (DALYs) worldwide, i.e. the number of life-years lost due to premature death and years lived with disability adjusted for severity, and accounts for 80-85% of all stroke incidents [1] . Ischemic stroke is caused by embolic or thrombotic obstruction of blood supply to the brain. An ischemic event triggers a complex molecular cascade including impaired cellular energy metabolism, cell depolarization, excitotoxicity, and disruption of the blood-brain barrier [1] . Depending on the duration of the Abstract Effective transplant-mediated repair of ischemic brain lesions entails extensive tissue remodeling, especially in the ischemic core. Neural stem cells (NSCs) are promising reparative candidates for stroke induced lesions, however, their survival and integration with the host-tissue post-transplantation is poor. In this study, we address this challenge by testing whether co-grafting of NSCs with olfactory ensheathing cells (OECs), a special type of glia with proven neuroprotective, immunomodulatory, and angiogenic effects, can promote graft survival and host tissue remodelling. Transient focal cerebral ischemia was induced in adult rats by a 60-min middle cerebral artery occlusion (MCAo) followed by reperfusion. Ischemic lesions were verified by neurological testing and magnetic resonance imaging. Transplantation into the globus pallidus of NSCs alone or in combination with OECs was performed at two weeks post-MCAo, followed by histological analyses at three weeks post-transplantation. We found evidence of extensive vascular remodelling in the ischemic core as well Ingrid Lovise Augestad and Axel Karl Gottfrid Nyman have contributed equally to this work. ischemic event, these pathophysiological changes can lead to extensive neuronal and glial cell injury and/or death, and axonal loss or demyelination, resulting in severe functional deficits [2] . The brain tissue where blood flow is most severely reduced comprises the ischemic core and is characterized by rapid pannecrosis. The ischemic core is surrounded by the ischemic penumbra, which represents salvageable tissue but only within a limited time frame [3] . At present, the only proven medical intervention for the treatment of acute stroke involves thrombolysis with tissue plasminogen activator and/or endovascular mechanical thrombectomy, and aims to dissolve the embolic or thrombotic obstruction. However, tissue plasminogen activator can only be administered within a maximum of 4.5 hours (h) after the onset of stroke [4] , which effectively excludes more than 85% of stroke patients from this treatment. Cell replacement therapy in the sub-acute or chronic stage offers the option of extending the narrow therapeutic window while addressing a key constituent of stroke pathophysiology, namely the cell loss caused by ischemia. In this context, a number of studies have demonstrated the potential of stem cell treatment in promoting tissue remodeling in animal models of ischemic stroke injury [5] [6] [7] [8] [9] .
Neural stem cells (NSCs) are self-renewing multipotent progenitors that can differentiate into both neurons and glia, a property that renders them highly relevant for central nervous system (CNS) repair [10, 11] . However, NSC survival post-engraftment is generally poor, especially in the ischemic core of large lesions [12] . Olfactory ensheathing cells (OECs), the glia surrounding the primary olfactory neurons throughout their trajectory from the olfactory mucosa to the olfactory bulb glomeruli, possess several attributes that make them particularly interesting in the repair of CNS lesions [13] . OECs secrete a host of growth factors, including vascular endothelial growth factor (VEGF), brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), and nerve growth factor (NGF), all of which are important for neural, glial and endothelial cell function as demonstrated in a number of experimental studies [14] [15] [16] [17] [18] [19] . Furthermore, compared to Schwann cells, OECs induce less astrocytic response in in vitro confrontation assays [20] as well as following transplantation into adult CNS white matter [21] . We have previously demonstrated the capacity of OECs to promote tissue remodelling, including axonal sparing and plasticity, neovascularization and remyelination after induced central axotomy [19] , while a recent clinical report suggests that OECs combined with Schwann cell transplants can promote functional regeneration of supraspinal connections after spinal cord injury [22] . Furthermore, growing evidence from experimental studies suggests that apart from being neuroprotective to injured neurons, OECs interact with astrocytic processes to form pathways that can help bridge the lesion cavity by providing a microenvironment permissive to axonal growth, a mechanism described as the 'pathway hypothesis', by providing structural as well as biochemical support [23, 24] . Taken together, the above attributes suggest that if OECs are co-engrafted with NSCs, they may enhance the viability and function of the NSC graft and synergistically act to achieve in situ tissue engineering after a focal ischemic lesion.
In this study, we used the middle cerebral artery occlusion (MCAo) model to induce transient focal cerebral ischemia in adult rats and investigated whether NSC and OEC co-transplants engrafted in the basal ganglia can promote tissue remodelling.
Materials and Methods

Cell Culture and Labelling
OECs from neonatal rats were purified as previously described [20] . Briefly, the olfactory bulbs of 4-5 P7 Sprague Dawley rats were harvested and finely chopped, then enzymatically digested in L-15 (Leibovitz) medium (Sigma), and triturated through a 26 gauge needle. Dissociated cells were incubated in a cocktail of O4 (IgM at 1:4) and anti-galactocerebroside (IgG3 at 1:2) primary antibodies (Clonetech), followed by their fluorochrome conjugated class specific secondary antibodies (Life Technologies). Further, dissociated cells were rinsed and then incubated in goat anti-mouse IgM phycoerythrin and goat anti-mouse IgG3 fluorescein secondary antibodies (1:100, Southern Biotech, Cambridge, UK). OECs were purified by fluorescence activated cell sorting (FACS) (Becton Dickenson, Oxfordshire, UK) by selecting for galactocerebrosidenegative and O4-positive cells. Subsequently, OECs were cultured in Dulbecco's Modified Eagle's Medium (DMEM) GlutaMAX ® (Sigma-Aldrich Company Ltd., Dorset, UK) with 1.25% gentamicin (Sigma), and 5% FBS (Autogen Bioclear, Wiltshire, UK) on 13 μg/ml poly-l-lysine-(PLL) (Sigma) coated 25 cm 2 flasks (Sigma). The cultures were supplemented with 500 ng/ml fibroblast growth factor 2 (FGF2) (Peprotech, London, UK), 50 ng/ml heregulin (hrgβ1) (R&D Systems Europe Ltd, Abingdon, UK), and 10-6 M forskolin (Sigma). Finally, OECs were passaged at confluence. Purity of the OECs populations was assessed by p75NTR specific labelling and was always at 98-100%. In order to investigate the distribution of OECs at the graft site, OECs were engineered to express enhanced green fluorescent protein (eGFP, Clontech, Living Colors). Shortly after purification, subconfluent cultures of OEC were infected overnight with transient supernatant taken from eGFP transfected phoenix cells, as previously described [17] 
Animal Procedures
All animal procedures were approved by the Norwegian ethics committee and were conducted in accordance with the relevant national, regional and site guidelines. Male Sprague Dawley rats (9 weeks old; 225-280 g, at start) were purchased from Scanbur AS. Cages were kept in a 12:12 h light/dark cycle, and animals had ad libitum access to food pellets and water.
Middle Cerebral Artery Occlusion (MCAo)
The animals were randomly assigned into two groups for surgery; (i) sham MCAo (n = 5) and (ii) MCAo (n = 30). Right middle cerebral artery occlusion (MCAo) was performed under anaesthesia with Hypnorm/Dormicum (Fluanizon/Fentanyl/Midazolam) using the intraluminal filament technique [25, 26] . The animals remained anaesthetized for 60 min when the monofilament was withdrawn to allow for reperfusion. Xylocaine spray 10 mg/ml (Astra Zeneca) was topically applied to the incision before suturing and returning the animals to their cages, where they were kept under observation and allowed to wake up. Postoperative food intake was supported by administration of pellets soaked in Nutridrink (Nutricia).
Verification of Stroke-Induced Brain Lesions
Verification of stroke lesions included neurological scoring using the Bederson scale in combination with T2-weighted magnetic resonance imaging (MRI) obtained at 1 week post-injury (wpi). For MRI, the animals were placed prone on a dedicated water-heated bed within a 7 T small animal scanner (Biospec 70/20 AS, Bruker Biospin MRI, Ettlingen, Germany) with water-cooled gradients (BGA-12S, 660 mT/m). An 86 mm volume resonator was used for radiofrequency (RF) transmission and a phased array rat head surface coil was used for RF reception. T2-weighted images were obtained under isoflurane anaesthesia (2% isoflurane in 30% O 2 /70% N2) using a rapid acquisition with relaxation enhancement (RARE) sequence with effective echo time (TE) = 30 ms; repetition time (TR) = 3700 ms; number of averages (NA) = 8; Rare Factor = 8; field of view (FOV) = 20.4 × 16 mm2; acquisition matrix 204 × 160; 32 coronal slices à 0.5 mm; scan time = 4 m 56 s. The T2-weighted images were scored by a blinded observer with experience in evaluating rat brain MR images. Inclusion criteria for allocation into treatment groups were defined as: animals with observed hyperintensities in the ipsilateral striatum, or ipsilateral cortex (S1 or S2), or ipsilateral thalamus, which also matched with a neurological score of >1 on the Bederson scale at 1wpi. Using these criteria, 17 (57%) animals were included for treatment randomization.
Intracranial Cell Transplantation
Based on post-operative neurological assessment and MRI data obtained at 1w after MCAo, animals with confirmed ischemic injury were randomly assigned into three groups for intrastriatal cell transplantation at 2wpi, as follows: (1) untreated controls (n = 4); injection of 3 μL saline, (2) NCS group (n = 6); injection of 3 μL of 3 × 10 5 NSC suspension, and (3) NSC and OEC group (n = 7); injection of 3 × 10 5 NSC-OEC suspension at a proportion of 50:50. For transplantation, the animals were placed in a rat head stereotactic frame (Kopf Instruments) under 1.5-2% isoflurane anaesthesia. Local anaesthesia was administered subcutaneously, before exposing the skull by midline incision. Injection coordinates were determined with reference to the Bregma, using the Paxinos Watson rat brain atlas (Elsevier) at AP-1.3, L-3.5, V-7.0, representing the ipsilesional globus pallidus, consistent with a previous study [7] . After making a burr hole, a total volume of 3 μL of cell suspension (or saline) was injected at a rate of 1 μL/min using a Hamilton syringe attached to an UltraMicroPump (UMP3) with SYS-Micro4 Controller (World Precision Instruments Ltd, Hitchin, Herdfordshire, UK). To avoid reflux, at the end of the injection, the needle was left inside the skull for another 2 min before being slowly withdrawn. The burr hole was subsequently sealed with sterile bee's wax and the incision sutured before the animals were returned to their cages. Immunosuppression was not considered necessary due to the relatively low immunogenicity of NSCs [27] and the fact that the OECs were homologously derived.
Cylinder Rearing Test
The animals' locomotor asymmetry was evaluated using the cylinder rearing test. Briefly, at 10 and 11 days postinjury (dpi), 4 days post-transplantation (dpx), and 21 dpx, animals were placed in a glass cylinder (67 cm tall, 15 cm diameter) and video recorded for 5 min (21) [28] . Three mirrors were arranged so that contacts between the forepaws and the cylinder wall could be monitored at all times. The videos were subsequently reviewed frame-by-frame separately by two observers blinded to experimental group assignment and the number of contacts between the forepaw and the cylinder wall were counted and registered as left (NL) or right (NR). Only contacts involving all digital pads and the palmar pads were registered. A normalized forepaw preference ratio (FP) was then calculated for each limb in each animal:
NL total × 100 = Left paw ratio, or NR total × 100 = Right paw ratio..
Intracardial Perfusion and Tissue Collection
At 3 wpx, the animals were sedated with 3.5% isoflurane, given a lethal injection of Pentobarbital (1mL/kg), and exsanguinated by means of intracardial perfusion with 50 mL chilled phosphate buffered saline (PBS) solution followed by 50 ml 4% paraformaldehyde. The whole brain was then removed and post-fixed in 4% paraformaldehyde at 4 °C overnight and cryoprotected by immersion in 30% sucrose for 2-3 days at 4 °C before being embedded in OCT compound (BDH), frozen in liquid nitrogen and stored at −80 °C.
Volumetry
Lesion volumes were calculated for each rat based on differences in hyperintensities in the T2 MR images using OsiriX (Pixmeo, Geneva, Switzerland) and an Intuos Creative Pen Tablet (Wacom Company, Ltd). The areas in each slice of the T2 scan from each rat that showed a hyperintense area relative to the contralateral hemisphere, were outlined using an Intuos Pen, before computing the ROI volume in OsiriX (Fig. 1) . Classification of lesion severity based on lesion volume computations was as follows: (i) small lesion: volume <40 µL (ii) moderate lesion: volume 40-80 µL; and severe lesion: volume >80 µL [29] .
Immunohistochemical Analyses of Brain Tissue
50 μm-thick sections of post-mortem tissue were serially collected using a Leica CM3050S cryostat and placed on Superfrost® Plus glass slides (Fisher Scientific). Immunohistochemistry included the following steps: immersion in blocking solution consisting of 5% goat serum and 0.3% Triton X-100 in phosphate buffered saline (PBS) for 1 h at room temperature (RT), followed by incubation with primary antibodies in a solution of 1% goat serum and 0.1% Triton-X in PBS at 4 °C overnight. Primary antibodies included: anti-nestin rabbit polyclonal antibody (dilution 1:1000), anti-CD68 mouse monoclonal antibody (1:1000); anti-GFP rabbit polyclonal antibody (1:500), anti-collagen IV rabbit polyclonal antibody (1:300), and mouse monoclonal anti-human nuclei (HuNu) (Merck Millipore). The sections were then washed three times in PBS before incubation with their class-specific secondary antibodies AlexaFluor 568 and AlexaFluor 488 (Invitrogen, Life Technologies) with Hoechst (1:5000) for 3h at RT. The sections were subsequently washed in PBS, coverslipped with Fluorsave (Merck Millipore), and imaged on an Olympus Scan R or Zeiss Axiovert A1 fluorescent microscope. Images were post-processed in Image J (U. S. National Institutes of Health, Bethesda, USA) for manual and automated cell counts.
Statistical Analyses
Statistical differences between groups were determined by two-way ANOVA (not repeated measures), paired t-tests using a significance level of 95%, and Fisher's exact test using Prism 7 for Mac OS X (GraphPad Software, Inc, San Diego, CA, USA). Post hoc power for paired t-tests was analysed using G*Power (Version 3.1.9.2).
Results
Verification and Evaluation of Severity of Stroke-Induced Lesions
T2-weighted magnetic resonance imaging (MRI) at one week (w) post-injury (wpi), associated with a neurological score of >1 on the Bederson scale, verified the presence of MCAo-induced brain lesions and subsequent inclusion of the animals in the study. The T2-weighted MR images revealed stroke-induced lesions in the form of hyperintensities observed primarily in the ipsilesional striatum, and/ or frontal, parietal, and temporal cortex, but also in varying degrees in the thalamus, hypothalamus, cervicomedullary junction and substantia nigra. As expected, the extent and degree of severity of the ischemic lesions induced by MCAo varied largely between rats (Fig. 1a-d) , thus mimicking the clinical situation [25, 30] . 3D reconstruction of the T2-weighted MR images (Fig. 1e, f) and volumetric analyses further confirmed the variability in lesion severity, showing lesion volumes ranging from 7.6-130.5 µL. For each experimental group the median and range (in brackets) of the lesion volumes were as follows: The saline group had a median of 113.7 µL (96.8-130.5 µL); the NSC group had a median of 17.05 µL (10.7-20.0 µL); and the NSC-OEC group had a median of 54.25 µL (7.6-128.2 µL).
Formation of NSC-OEC Networks In Vitro
In vitro NSC and OEC co-culture assays revealed gradual formation of distinct OEC networks interlaced with NSCs (Fig. 2) . Optimal cell dispersal and survival were achieved with a proportion of 50:50 in NSC:OEC cocultures fed with NSC media. Specifically, we found that this proportion resulted in homogeneous co-cultures in which both cells attached and displayed normal morphology, and where the cells covered the entire surface of the wells, without leaving any areas unpopulated and without any aggregation of either cell type in separate parts of the wells. Furthermore, these co-cultures yielded average cell counts of NSCs and OECs (expressed as mean ± standard deviation per unit area) of 34,532 ± 3369 and 19,021 ± 2774/cm 2 , respectively, at 48 h post-seeding. This was comparable to the cell counts obtained from control cultures of each cell type separately at the same time point (NSCs: 38,119 ± 2208/cm 2 ; OECs: 21,006 ± 4595/cm 2 ).
Cell Survival, Motility and Vascular Remodelling Post-Transplantation
Contrary to the in vitro observations, we found little evidence of network formation in NSC-OEC grafts in situ at 3w post-transplantation (wpx) in the globus pallidus. Indeed, the two cell types appeared to form separate clusters, with OECs aggregating in the core of the graft and NSCs localised in the graft periphery (Fig. 3a-c ).
These observations were only made in animals with small ischemic lesions (lesion volume <40 μL), in which the basal ganglia were not severely affected. As expected, NSC and NSC-OEC graft survival was better in animals with less severe lesions. Relatively good survival was observed for both cell types in the NSC-OEC grafts, albeit with NSC numbers on average 63% ± 14.4 higher than those of OECs. In these animals, both types of cells appeared to form tight clusters within the original graft location with OECs always aggregating in the centre of the graft (Fig. 3a-c) . NSC-OEC grafts appeared much less clustered and more dispersed in animals with moderate and severe lesions (lesion volumes 40-80 μL, and >80 μL, respectively) ( Fig. 3d-f) , while overall NSC survival in these animals was significantly higher in the NSC-OEC group compared to NSC only (average number of NSCs/ counting frame NSC/OEC group 87.6 ± 24.3, versus NSC group 31.3 ± 18.6; two-tailed p < 0.05; Fisher's exact test).
In general, OEC survival was relatively poorer than that of NSCs, especially in animals with severe lesions, in which very few OECs (< 1% of transplanted cells) were found. In co-grafted animals with moderate lesions, the average proportion of OECs per counting frame was 43.8 ± 11%. However, overall NSC survival in co-grafted animals with small and moderate lesions tended to be better than that of OECs (p = 0.054; Fisher's exact test). It is not clear whether the relative absence of OECs from animals with severe lesions can be attributed to cell death or to possible migration away from the engraftment site post-transplantation. However, we did not find any evidence of OEC migration regardless of lesion severity. Instead, we found notable NSC migration from the lesion core and into the infarct border in animals with moderate and severe lesions (Fig. 4) as well as NSC migration from the graft site to the ipsilesional corpus callosum in animals with small lesions (Fig. 5) . Furthermore, immunostaining against nestin (Fig. 5b) and anti-human nuclei antibody (Fig. 5c ) revealed larger numbers of NSCs than originally indicated by the PKH26 stain (Fig. 5a) , suggesting that PKH26 staining may underestimate the survival and/or migration of the engrafted NSCs post-transplantation. Interestingly, extensive vascular remodelling in the lesion core was observed in animals with severe lesions and NSC-OEC grafts at 3wpx (Fig. 6 ).
Behavioural Assessment
To assess forelimb functional asymmetries, the Cylinder Rearing Test was administered on day 10, 11, 16, and 28 post MCAo. A two-way repeated measures ANOVA showed no significant effects between left versus right forelimb preference, nor across timepoints (F(2,14) = 3.631). Paired t-tests showed no significant differences in right or left forelimb use within each group between day 10 and 28, i.e. before and after treatment (p > 0.05) (Fig. 7) . Post hoc power analysis of results from the paired t-tests yielded very low power (π> 0.105). This was expected due to the low number of animals in each group. However, there was an increased left forepaw preference in the saline treated control group, indicative of a trend towards improvement (p = 0.295, η² = 0.744).
Discussion
The formation of OEC networks in the in vitro co-culture with NSCs may constitute a predictor of OEC function post-transplantation. In particular, the self-organization of OECs into relatively continuous elongated network-like structures in the culture seemed to partially recapitulate the natural orientation of these cells in their resident milieu, in which they align themselves with the axons of primary olfactory neurons [13] . Although we found no direct evidence of in situ OEC network formation post-transplantation, our results suggest a possible role of OECs in promoting tissue remodeling after stroke.
In particular, the evidence of an extensive vascular network in the lesion core of severely lesioned animals cografted with OECs could be attributed to potential stimulation of angiogenesis through local VEGF secretion from the transplanted OECs. Similarly, the overall NSC survival in animals that received NSC-OEC grafts suggests potential neuroprotective effects of the OECs on the transplanted NSCs, possibly through secretion of neurotrophic factors and cytokines. This is in accordance with previous findings, showing optimal effects of co-grafting NSCs with OECs in terms of promoting NSC survival and neuronal restoration after experimental traumatic brain injury and Parkinson's disease [31, 32] .
Furthermore, our findings might be in agreement with the 'pathway hypothesis' [33] , according to which OECs may promote remodeling of disrupted neuronal pathways by acting as bridges which provide structural and/or biochemical support to regenerating axons or cell transplants [34, 35] .
Specifically, we found evidence of NSC migration away from the graft, having moved from inside the lesion core and into the infarct border. Although we did not observe any OECs in the graft core or in the infarct border in these animals, the finding of a vascular network in the lesion core, coupled to the presence of migrating nestin-positive NSCs in the infarct border, may constitute indirect proof of structural and biochemical support involving juxtacrine and/or paracrine effects attributable to the engrafted OECs. On the other hand, it would be difficult to justify the absence of OECs from these tissues as a result of potential cell death, given that the degree of vascular remodeling observed in the lesion core should also have supported the longer-term in situ survival of the engrafted OECs, in addition to that of the NSCs. Thus, one explanation could be that ability to detect the transplanted OECs based solely on the expression of the GFP reporter gene may be severely compromised, especially in animals with more severe ischemic lesions. This is because formation of the GFP fluorophore requires molecular oxygen to catalyze its posttranslational cyclization [36, 37] , implying that this process may have been adversely affected by the hypoxic conditions prevailing in the lesion core post-transplantation, leading to gradual loss of GFP expression and, effectively, inability to retrieve it, even with the use of an anti-GFP antibody. An alternative explanation for the lack of observable OECs is that the cells may have ultimately migrated to other sites in the brain or entered the lateral ventricle, as previously reported for different intraparenchymal cell transplants after MCAo [38] [39] [40] .
Another interesting perspective is how NSCs together with OECs may synergistically support in situ tissue remodeling after stroke injury. In a similar way in which NSC survival and integration with the host tissue may be promoted by the presence of OECs in the graft, as observed in animals with less severe lesions, the relatively good survival of the OECs in the same animals may in turn be attributed to trophic support by the transplanted NSCs [41] . Notwithstanding the fact that reduced lesion severity will have provided a more favorable microenvironment in the host parenchyma, OEC survival post-transplantation in lesioned CNS tissue is generally expected to be poor [42] . Thus survival of OECs in these tissues may have been promoted by the presence of NSCs in the graft. Furthermore, given that a less severe lesion would also involve a less hypoxic host microenvironment, GFP expression in the transplanted OECs may not have been particularly affected, thus resulting in improved detectability. Overall, the difficulty of detecting surviving OECs based on GFP expression, might have been circumvented with the use of an OEC-specific antibody. However, in the absence of an unequivocal marker for OECs [42, 43] , further immunostaining (i.e. in addition to anti-GFP antibody) for the purpose of identifying more surviving/migrating OECs was not relevant. In addition Two-way ANOVA (not repeated measures) did not find any significant differences between left and right forelimb, or between time points to the above, the tendency for aggregation of both NSCs and OECs in the original graft location, as opposed to any observable homing to other parts of the brain, could be explained by lower host tissue inflammation. Especially with regard to NSC transplants, their recruitment to affected parts of the brain is mediated by an increase in chemokine and cytokine production in response to the ischemic lesion [44] . Clearly, this effect can be expected to be less pronounced in smaller lesions.
Still, we found evidence of callosal migration in the form of NSC clusters aligned with the ipsilesional corpus callosum in animals with less severe lesions. Cross-callosal, transhemispheric migration has previously been reported, especially for bone-marrow stromal cells. However, in those cases the stem cells were originally transplanted in the contralesional hemisphere after stroke induced injury [6, 45] . Furthermore, after ischemic lesion, intracortically transplanted NSCs have been shown to migrate away from the initial graft location and to align themselves with the corpus callosum [46] . These and other studies suggest that NSCs are able to migrate to parts of the brain remote from the original graft locations along white matter tracts. Notwithstanding the possibility that the observed NSCs aligned with the ipsilesional corpus callosum might be derived from a residual population at the dorsal end of the injection tract as a result of needle withdrawal post-injection, the absence of a visible needle tract in the tissue and the fact that the NSCs are also localized in sections anterior to the transplantation site, suggest that their presence in the corpus callosum may be the result of migration away from the globus pallidus, i.e. the transplantation site. Considering the relatively small lesion severity, NSC migration along existing white matter tracts, irrespective of any synergistic effects mediated by OECs should be possible.
The cylinder rearing test revealed no significant differences in the use of the contralesional (left) forepaw over time in either of the treatment groups, but indicated a trend towards improvement in the saline treated control group, which may be consistent with spontaneous functional recovery [47, 48] . The lack of improvement in forepaw preference after NSC or NSC-OEC transplantation is not surprising, considering that any functional benefits as a result of the treatment would be marginal, and thereby difficult to evaluate at 3wpx. Furthermore, small group sizes, as here, are sensitive to type II errors, especially when considering both limb, group and time in the same analysis as in this study.
Moreover, systematic bias due to individual differences between the rats' preferred forelimb use cannot be excluded [28, 49] . Thus, although the cylinder test may be useful for verifying stroke-induced functional deficits, its value in the assessment of gain of function in the present study may be limited.
Finally, a relevant point in the above discussion is the extent to which the choice of experimental model, i.e. 60-min MCAo, may have impacted our findings. This specific model is well-characterized in the literature and has been used in a number of experimental studies of transient focal cerebral ischemia, including studies investigating intrastriatal stem cell transplantation [7, [50] [51] [52] [53] . However, one challenge associated with the MCAo model is that it is known to result in lesions of variable severity [7, 29, 53, 54] . While this per se may be considered positive in terms of the extent to which the MCAo model can recapitulate the variability observed in stroke patients, such differences in lesion severity, coupled to the strict criteria which were applied for the inclusion of lesioned animals in the study, did result in relatively small group sizes. Another relevant point here is the randomization procedure for animal allocation into groups. On this occasion, the randomization process resulted in differences in lesion severity between groups. A pseudorandom allocation would have helped avoid this situation.
Taken together, our findings demonstrated that cotransplantation of NSCs with OECs can promote vascular and/or tissue remodeling in the ischemic brain as a result of synergistic effects of the two cell types. Clearly, this was contingent on the extent of lesion severity. However, an important finding in our study was the evidence of OEC effects on in situ remodeling in more severe ischemic lesions, which seems to be in agreement with the pathway hypothesis. Notwithstanding that the variability of lesion pathology between subjects in a given cohort post-MCAo may confound a thorough elucidation of the exact mechanisms involved, it is worth considering how future strategies for stroke repair may involve OECs as part of an in situ tissue engineering paradigm as an alternative to or in combination with other approaches, as for example tailored biomaterials [6, 7, 29, 55] . Such approaches, which incorporate state-of-the-art advances in the field [56] are highly promising with a view to preserving and/or restoring host tissue as well as optimizing implant-derived effects that enhance brain plasticity for functional restoration [6, 56] .
